BRIEF-Bayer To Voluntarily Discontinue U.S. Sales Of Essure At End Of 2018

July 20 (Reuters) - Bayer AG:

* BAYER SAYS TO VOLUNTARILY DISCONTINUE U.S. SALES OF ESSURE SYSTEM FOR PERMANENT BIRTH CONTROL AFTER DECEMBER 31

* BAYER - DECISION TO DISCONTINUE U.S. SALES OF ESSURE BASED ON DECLINING U.S. SALES, CONCLUSION THAT ESSURE BUSINESS "NO LONGER SUSTAINABLE"

* BAYER SAYS HAS INFORMED U.S. FDA OF CO'S DECISION TO DISCONTINUE U.S. SALES OF ESSURE

* BAYER SAYS "THE SAFETY AND EFFICACY OF ESSURE HAVE NOT CHANGED" Source text for Eikon: Further company coverage: